RE: Regeneron sells 1.25M doses to U.S.13 Jan 2021 17:17
Scinv - losing future revenue because of legitimate competitions and us moving too slowly - that I completely agree with. But I'm not following your off-branded inhaled ifn theory today. Just can't see how that will eat into our (low-volume) revenues, even if quacks start mixing their own ****tails behind the closed doors.
Home trial PII will probably land soon (by end of Feb at the latest?), but no idea what effect it will have on EUA or SP. Original P3 2-6 months according to RM, probably 2-4 since we've cut down 300. But presence of data monitoring committee (afaik) means P3 doesn't actually have to finish before any reviews.
Not even front page on the website though. Not the main article for covid or UK any more - instead we have a big photo of handjob's mug telling us all to stay home and thanking the NHS for their hard work despite any government support...
Let's see if RM can deliver half of his 100k promise by the end of the month. That's one of the main remaining concerns now. Albeit, if Activ-2 is successful, it would be warp speed in charge of manufacturing, wouldn't it?
welsh - afaik long covid mainly comes from long-term organ damage, not long-term ifn deficiency? SNG would be safe for anyone at any stage it seems, but I don't think it will have any impact on anyone who already has long covid. It might work well to prevent future cases in people who just caught it.
nae - not quite. There's a data monitoring committee on the trial and we get extra data from the home trial (imminently I guess lol). They don't have to wait until the end of the trial to grant EUA. Also, things are getting desperate with covid globally. Activ-2... Rm said there's a possibility of interim review if trial not filling fast.